Cumulative number of drugs with biosimilars approved US and Europe 2006-2018

Cumulative number of medicines with biosimilars approved in the U.S., Europe, and Canada from 2006 to 2018*

Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

May 2020

Region

Canada, Europe, United States

Survey time period

2006 to 2018

Supplementary notes

* All available trade names are counted as one biosimilar medicine (e.g., multiple biosimilar trade names referencing the same originator biologic).

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Medical biotech industry "

Other statistics that may interest you Medical biotech industry

Global overview

7

U.S. and European landscape

6

Focus: U.S. companies

8

Research & development

6

Products

5

Funding/M&A/IPOs

6

Focus: RNA/mRNA

4

Further related statistics

10
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.